EXACT Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Per Walday
Chief executive officer
kr2.8m
Total compensation
| CEO salary percentage | 80.2% |
| CEO tenure | 2yrs |
| CEO ownership | n/a |
| Management average tenure | 1.9yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?
Apr 20
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth
Sep 07We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely
May 06Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation
Dec 30Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth
Sep 15EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans
Jan 31We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth
Aug 21We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate
May 21CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | kr3m | kr2m | -kr48m |
| Sep 30 2023 | n/a | n/a | -kr42m |
| Jun 30 2023 | n/a | n/a | -kr36m |
| Mar 31 2023 | n/a | n/a | -kr38m |
| Dec 31 2022 | kr2m | kr1m | -kr40m |
Compensation vs Market: Per's total compensation ($USD268.55K) is about average for companies of similar size in the Norwegian market ($USD319.46K).
Compensation vs Earnings: Per's compensation has increased whilst the company is unprofitable.
CEO
Per Walday (64 yo)
2yrs
Tenure
kr2,833,302
Compensation
Dr. Per Walday, Ph D., has been the Chief Executive Officer at PCI Biotech AS since 2008. He serves as Chief Executive Officer at EXACT Therapeutics AS since June 5, 2022.Dr. Walday had been the Chief Exe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2yrs | kr2.83m | no data | |
| Vice-Chair of the Board | 9.4yrs | kr445.00k | no data | |
| Co Founder & COO | no data | kr1.65m | 9.43% NOK 22.4m | |
| Chief Financial Officer | 1.7yrs | kr2.02m | no data | |
| Chief Medical Officer | 1.8yrs | kr2.66m | no data | |
| Senior Vice President of Commercial & Business Development | less than a year | kr250.00k | no data | |
| Founder | no data | kr2.49m | 5.99% NOK 14.2m | |
| Vice President of Technology | 2.2yrs | no data | no data |
1.9yrs
Average Tenure
Experienced Management: EXTX's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice-Chair of the Board | 9.4yrs | kr445.00k | no data | |
| Director | 6.4yrs | kr275.00k | 1.05% NOK 2.5m | |
| Chair of the Board | 2.5yrs | kr510.00k | no data | |
| Director | 3yrs | kr260.00k | no data |
4.7yrs
Average Tenure
Experienced Board: EXTX's board of directors are considered experienced (4.7 years average tenure).